Application portal opens Sept. 1 each year and application deadline is Dec. 10. Interview Weekend, for those applicants who are extended invitations, is the third week of Feb.

The procedures for admission to the graduate program in Pharmacology & Experimental Therapeutics are described through the Graduate Medical Sciences admissions page. Applicants must submit the online application form that includes a statement of purpose. Applications are reviewed on a rolling basis once complete. Students are encouraged to arrange for the submission of official transcripts as well as two letters of recommendation well in advance of the due date of December 1, which is when the application portal will close. GRE scores are not required for application to the graduate program and the absence of such scores will not adversely affect the consideration of any applicant. However, students may submit GRE scores at their sole discretion. Students often ask about the criteria for admission.

In addition to strong performance in academic coursework, most successful applicants will provide evidence of prior laboratory research experience and a strong rationale for their decision to apply for predoctoral training at the NIGMS Program in Biomolecular Pharmacology at Boston University. Applications are reviewed by the Admissions Committee for the Department, which forwards recommendations to the Graduate Education Committee and Department Chair. Invitations to visit and meet students, faculty and staff will be extended to those who appear to be a good match for the unique aspects of our training program.  A personal interview is required for applicants for the Ph.D. and M.D.-Ph.D. programs, and applicants to the M.A. program are also encouraged to visit. Applicants are encouraged to carefully review the research interests of program faculty prior to submitting their applications and indicate which research areas of emphasis and faculty members they would like to meet in person.  Following interviews, applicants will be notified of admissions decisions by the Department Chair and the Associate Provost of Graduate Medical Sciences.



In this section: